poteligeo
kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antinavikiniai vaistai - poteligeo fluorouracilu ir folino suaugusių pacientų su mycosis fungoides (mf), arba sézary sindromas (ss), kurie gavo bent vieną prieš sisteminės terapijos.
bendamustine sandoz
sandoz d.d. - bendamustino hidrochloridas - milteliai infuzinio tirpalo koncentratui - 2,5 mg/ml - bendamustine
lenalidomide grindeks
as grindeks - lenalidomidas - kietosios kapsulės - 15 mg - lenalidomide
bendamustine accord
accord healthcare b.v. - bendamustino hidrochloridas - koncentratas infuziniam tirpalui - 25 mg/ml - bendamustine
bendamustine hydrochloride boston biopharma
boston biopharma lt, uab - bendamustino hidrochloridas - milteliai infuzinio tirpalo koncentratui - 2,5 mg/ml - bendamustine
thalidomide lipomed
lipomed gmbh - talidomidas - daugybinė mieloma - imunosupresantai - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
plerixafor auxilia
auxilia pharma oÜ - pleriksaforas - injekcinis tirpalas - 20 mg/ml - plerixafor